XSEER PHARMACEUTICALS
Live / Registered — Registered (as of 21 Oct 2025)
What this means for you
Registered since 21 Oct 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98385105
- Registration number
- 7996199
- Mark type
- Design + words
- Filed
- 31 Jan 2024
- Published for opposition
- 17 Dec 2024
- Registered
- 21 Oct 2025
- Attorney of record
- Dean G. Stathakis
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of obesity, senescence, male hypogonadism, muscle loss, lack of energy, lack of focus, sexual dysfunction, hormone-based disease or disorder; Pharmaceutical preparations for hormone replacement therapy, weight management therapy, antioxidant therapy, intravenous administration therapy for treating or preventing obesity, senescence, male hypogonadism, muscle loss, lack of energy, lack of focus, sexual dysfunction, hormone-based diseases or disorders, anti-aging therapy
Owner
- Xseer Pharmaceuticals, Los Angeles, CA, US
- Xseer Pharmaceuticals, Los Angeles, CA, US
- Xseer Pharmaceuticals, Los Angeles, CA, US
Prosecution history
- 21 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Oct 2025 — REGISTERED-PRINCIPAL REGISTER
- 01 Oct 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Oct 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Sept 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 02 May 2025 — USE AMENDMENT FILED
- 30 Sept 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 May 2025 — TEAS STATEMENT OF USE RECEIVED
- 11 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Dec 2024 — PUBLISHED FOR OPPOSITION
- 11 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Nov 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 Nov 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE